Labcorp Holdings Inc.
LH Healthcare Diagnostics & Research
Labcorp Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.0 billion, up 7.25% from fiscal 2024. In the quarter to June 2026, revenue grew 5.78%, EPS grew 28.4%, free cash flow fell 42.0% and total debt rose 15.1%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for five consecutive years, revenue growth for three.
Follow LH
Labcorp Holdings Inc. (LH) Revenue
Labcorp Holdings Inc.'s revenue for fiscal 2025 was $14.0B, up 7.25% from $13.0B in fiscal 2024. Over the twelve months to 30 June 2026 it was $14.3B. Over the past ten years it has ranged from $8.7B (fiscal 2015) to $14.0B (fiscal 2020); the current reading is higher than 91% of that period. Revenue has risen for 3 consecutive fiscal years. Labcorp Holdings Inc. ranks 4th of 50 Diagnostics & Research companies by revenue.
Revenue, annual
Embed this chart
Annual newest first
| Period | Revenue | Change |
|---|---|---|
| FY2025 | $14.0B | 7.25% |
| FY2024 | $13.0B | 6.97% |
| FY2023 | $12.2B | 2.51% |
| FY2022 | $11.9B | (9.68%) |
| FY2021 | $13.1B | (6.03%) |
| FY2020 | $14.0B | 20.98% |
| FY2019 | $11.6B | 1.95% |
| FY2018 | $11.3B | 9.95% |
| FY2017 | $10.3B | 7.90% |
| FY2016 | $9.6B | 10.06% |
Quarterly newest first
| Period | Revenue | Change |
|---|---|---|
| Jun 2026 | $3.7B | 5.47% |
| Mar 2026 | $3.5B | 0.62% |
| Dec 2025 | $3.5B | (1.34%) |
| Sep 2025 | $3.6B | 1.03% |
| 42 more quarters | Free account |
Against its own ten years
Revenue against peers
| Company | Revenue |
|---|---|
| LH Labcorp Holdings Inc. | $14.3B |
| DGX Quest Diagnostics Incorporated compare | $11.6B |
| WAT Waters Corporation compare | $4.6B |
| IDXX IDEXX Laboratories, Inc. compare | $4.6B |
| ILMN Illumina, Inc. compare | $4.5B |
| MTD Mettler-Toledo International, Inc. compare | $4.1B |
| RVTY Revvity Inc. compare | $2.9B |
| MEDP Medpace Holdings, Inc. compare | $2.8B |
| GH Guardant Health, Inc. compare | $1.2B |
What Revenue is
Revenue tells an investor how much a company brought in from selling its goods and services over a period, before any costs are taken out.
Reported line item
More on LH
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement